Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Beagle, Brandon
NCT05069935: FT538 in Combination With Monoclonal Antibodies in Advanced Solid Tumors	Terminated	1	16	US	FT538, NK Cell Therapy, Cyclophosphamide, Cy, Fludarabine, Flu, Monoclonal antibody - Dose Escalation, mAb, Monoclonal antibody - Dose Expansion	Fate Therapeutics	Solid Tumor, Adult	08/23	08/23